rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
4
|
pubmed:dateCreated |
2008-10-31
|
pubmed:abstractText |
Patients at high risk of cardiovascular disease frequently fail to reach recommended low-density lipoprotein cholesterol (LDL-C) goals, partly because statin doses are not titrated to optimal effect. The ECLIPSE study was designed to compare the efficacy and safety of force-titrated treatment with rosuvastatin (10-40 mg) with that of atorvastatin (10-80 mg) in high-risk patients with hypercholesterolemia.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:issn |
1421-9751
|
pubmed:author |
|
pubmed:copyrightInfo |
Copyright 2008 S. Karger AG, Basel.
|
pubmed:issnType |
Electronic
|
pubmed:volume |
111
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
219-28
|
pubmed:dateRevised |
2009-5-18
|
pubmed:meshHeading |
pubmed-meshheading:18434729-Aged,
pubmed-meshheading:18434729-Canada,
pubmed-meshheading:18434729-Cholesterol, LDL,
pubmed-meshheading:18434729-Coronary Disease,
pubmed-meshheading:18434729-European Union,
pubmed-meshheading:18434729-Female,
pubmed-meshheading:18434729-Fluorobenzenes,
pubmed-meshheading:18434729-Heptanoic Acids,
pubmed-meshheading:18434729-Humans,
pubmed-meshheading:18434729-Hydroxymethylglutaryl-CoA Reductase Inhibitors,
pubmed-meshheading:18434729-Hypercholesterolemia,
pubmed-meshheading:18434729-Male,
pubmed-meshheading:18434729-Middle Aged,
pubmed-meshheading:18434729-Pyrimidines,
pubmed-meshheading:18434729-Pyrroles,
pubmed-meshheading:18434729-Risk Assessment,
pubmed-meshheading:18434729-Risk Factors,
pubmed-meshheading:18434729-Sulfonamides
|
pubmed:year |
2008
|
pubmed:articleTitle |
Efficacy and tolerability of rosuvastatin and atorvastatin when force-titrated in patients with primary hypercholesterolemia: results from the ECLIPSE study.
|
pubmed:affiliation |
Aarhus Sygehus University Hospital, Aarhus, Denmark.
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|